{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:20:11Z","timestamp":1791062411721,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":55,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007698.pub2","type":"reference-entry","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T15:29:57Z","timestamp":1285687797000},"source":"Crossref","is-referenced-by-count":25,"title":["Oral budesonide for induction of remission in ulcerative colitis"],"prefix":"10.1002","author":[{"given":"Mary E","family":"Sherlock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia H","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Hillary","family":"Steinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD007698.pub2-BIB1|cit1","first-page":"A505","article-title":"Safety and efficacy of a novel extended release budesonide formulation in patients with active left-sided ulcerative colitis","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007698.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.crohns.2009.09.007","article-title":"Clinical trial: Preliminary efficacy and safety study of a new budesonide-MMX\u00ae 9 mg extended-release tablets in patients with active left-sided ulcerative colitis","volume":"4","author":"D'Haens","year":"2010","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007698.pub2-BIB3|cit3","first-page":"A15","article-title":"Efficacy and tolerability of a once daily treatment with budesonide capsules versus mesalamine granules for the treatment of active ulcerative colitis: a randomized, double-blind, double-dummy, multicenter study","volume":"136","author":"Gross","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007698.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/gast.1996.v110.pm8964395","article-title":"Oral budesonide versus prednisone in patients with active extensive and left-sided ulcerative colitis","volume":"110","author":"L\u00f6fberg","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD007698.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.MIB.0000192323.82426.83","article-title":"Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice","volume":"12","author":"Chopra","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1002\/14651858.CD007698.pub2-BIB6|cit6","first-page":"802","article-title":"Advances in the topical steroid treatment of inflammatory bowel disease","volume":"87","author":"D\u00edas Blasco","year":"1995","journal-title":"Rev Esp Enferm Dig"},{"issue":"6","key":"10.1002\/14651858.CD007698.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1053\/gast.1996.v110.agast962000","article-title":"Budesonide therapy for ulcerative colitis: a topical tale","volume":"110","author":"Feagan","year":"1996","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD007698.pub2-BIB8|cit8","first-page":"525","article-title":"Budesonide and inflammatory bowel disease","volume":"22","author":"Gomoll\u00f3n","year":"1999","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"10.1002\/14651858.CD007698.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.1997.00263.x","article-title":"Oral budesonide therapy for steroid-dependent ulcerative colitis","volume":"11","author":"Keller","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1002\/14651858.CD007698.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1358\/dot.2004.40.7.850477","article-title":"Evaluation of oral budesonide in the treatment of active distal ulcerative colitis","volume":"40","author":"Kolkman","year":"2004","journal-title":"Drugs Today (Barc)"},{"issue":"5","key":"10.1002\/14651858.CD007698.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4321\/S1130-01082006000500007","article-title":"Budesonide for ulcerative colitis","volume":"98","author":"Mar\u00edn-Jim\u00e9nez","year":"2006","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1002\/14651858.CD007698.pub2-BIB12|cit12","unstructured":"Efficacy and Safety of Oral Budesonide-MMX TM (CB-01-02) 6 mg and 9 mg Extended Release Tablets in Patients With Mild or Moderate Active Ulcerative Colitis. A Multicenter, Randomized, Double-Blind, Double-Dummy, Comparative Study Versus Placebo With an Additional Reference Arm Evaluating Entocort\u00ae EC Ongoing study"},{"key":"10.1002\/14651858.CD007698.pub2-BIB13|cit13","unstructured":"Efficacy and Safety of New Oral Budesonide-MMX\u00ae (CB-01-02) 6 mg and 9 mg Extended Release Tablet Formulations in Patients with Mild or Moderate, Active Ulcerative Colitis. A Multicenter, Randomized, Double-Blind, Double Dummy Comparative Study Versus Placebo, with an Additional Reference Arm Evaluating Asacol\u00ae 2400 mg. Ongoing study"},{"issue":"7","key":"10.1002\/14651858.CD007698.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10350-004-6687-x","article-title":"Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis","volume":"46","author":"Bar-Meir","year":"2003","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1002\/14651858.CD007698.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2005.05.003","article-title":"Molecular mechanisms and cellular effects of glucocorticosteroids","volume":"25","author":"Barnes","year":"2005","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9573","key":"10.1002\/14651858.CD007698.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007698.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00005176-199605000-00006","article-title":"Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis","volume":"22","author":"Beattie","year":"1996","journal-title":"J Pediatr Gastroenterol Nut"},{"key":"10.1002\/14651858.CD007698.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2007.12.001","article-title":"European evidence-based consensus on the management of ulcerative colitis: special situations","volume":"2","author":"Biancone","year":"2008","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD007698.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00365529209011158","article-title":"A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis","volume":"27","author":"Danielsson","year":"1992","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1002\/14651858.CD007698.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"issue":"18","key":"10.1002\/14651858.CD007698.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/14651858.CD007698.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.addr.2004.08.009","article-title":"Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide","volume":"57","author":"Fedorak","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1002\/14651858.CD007698.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bpg.2004.01.002","article-title":"Specificities of inflammatory bowel disease in childhood","volume":"18","author":"Griffiths","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD007698.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2036.1997.tb00814.x","article-title":"Review article: Drug development in inflammatory bowel disease: budesonide - a model of targeted therapy","volume":"11","author":"Hamedani","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/14651858.CD007698.pub2-BIB25|cit25","first-page":"1188","article-title":"Mesalamine capsules for the treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group","volume":"88","author":"Hanauer","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/14651858.CD007698.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"7414","key":"10.1002\/14651858.CD007698.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007698.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1002\/14651858.CD007698.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.mcg.0000170735.43887.3a","article-title":"Update in medical therapy of ulcerative colitis: newer concepts and therapies","volume":"39","author":"Katz","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD007698.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3748\/wjg.v7.i2.175","article-title":"Historical origins of current IBD concepts","volume":"7","author":"Kirsner","year":"2001","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD007698.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.14.354","article-title":"Treatment of inflammatory bowel disease: a review of medical therapy","volume":"14","author":"Kozuch","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1002\/14651858.CD007698.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/01.mib.0000235827.21778.d5","article-title":"Recent understanding of IBD pathogenesis: implications for future therapies","volume":"12","author":"Kucharzik","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1002\/14651858.CD007698.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.MIB.0000217770.21261.ce","article-title":"Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study","volume":"12","author":"Lakatos","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"8706","key":"10.1002\/14651858.CD007698.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0140-6736(90)91521-B","article-title":"Preliminary report: cyclosporin in treatment of severe active ulcerative colitis","volume":"336","author":"Lichtiger","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007698.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.1.2.87","article-title":"Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis","volume":"1","author":"Lockhart-Mummery","year":"1960","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD007698.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0025-7753(01)71716-2","article-title":"Budesonide in inflammatory bowel disease: a meta-analysis","volume":"116","author":"Nos","year":"2001","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"10.1002\/14651858.CD007698.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365527809182199","article-title":"A comparison of oral predisolone given as single or multiple daily doses for active proctocolitis","volume":"13","author":"Powell-Tuck","year":"1978","journal-title":"Scand J Gastroenterol"},{"issue":"6666","key":"10.1002\/14651858.CD007698.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalamine (5-aminosalicylic acid) versus sulphasalazine in active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007698.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"issue":"23","key":"10.1002\/14651858.CD007698.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1002\/14651858.CD007698.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007698.pub2-BIB42|cit42","first-page":"1079","article-title":"Modalities of corticosteroid therapy in inflammatory bowel disease","volume":"74","author":"Sabate","year":"1998","journal-title":"Sem H\u00f4p Paris"},{"issue":"1","key":"10.1002\/14651858.CD007698.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00535-006-1995-7","article-title":"Inflammatory bowel disease: past, present, and future","volume":"42","author":"Sands","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1002\/14651858.CD007698.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0016-5085(86)90376-8","article-title":"Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-graunlocyte excretion","volume":"90","author":"Saverymuttu","year":"1986","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1002\/14651858.CD007698.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Eng J Med"},{"issue":"8","key":"10.1002\/14651858.CD007698.pub2-BIB46|cit46","first-page":"971","article-title":"An index of disease activity in patients with ulcerative colitis","volume":"87","author":"Seo","year":"1992","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD007698.pub2-BIB47|cit47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000296.pub3","article-title":"Budesonide for the induction of remission in Crohn's disease","author":"Seow","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007698.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007698.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJM199808063390603","article-title":"A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group","volume":"339","author":"Thomsen","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1002\/14651858.CD007698.pub2-BIB50|cit50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000478.pub2","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","author":"Timmer","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"s1","key":"10.1002\/14651858.CD007698.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2036.2006.03070.x","article-title":"Review article: induction therapy for patients with active ulcerative colitis","volume":"24","author":"Travis","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1002\/14651858.CD007698.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2(4947)","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"issue":"2","key":"10.1002\/14651858.CD007698.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD007698.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"issue":"7152","key":"10.1002\/14651858.CD007698.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007698.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007698.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T20:30:47Z","timestamp":1711830647000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007698.pub2"}},"subtitle":[],"editor":[{"given":"Mary E","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007698.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007698.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2010,10,6]]}}}